7.95
前日終値:
$8.14
開ける:
$8.2
24時間の取引高:
13,794
Relative Volume:
0.02
時価総額:
$10.54M
収益:
$1.47M
当期純損益:
$-97.61M
株価収益率:
-5.3356
EPS:
-1.49
ネットキャッシュフロー:
$-80.90M
1週間 パフォーマンス:
+0.63%
1か月 パフォーマンス:
-35.37%
6か月 パフォーマンス:
-15.25%
1年 パフォーマンス:
-48.54%
Lyra Therapeutics Inc Stock (LYRA) Company Profile
LYRA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
LYRA
Lyra Therapeutics Inc
|
7.95 | 13.01M | 1.47M | -97.61M | -80.90M | -1.49 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-05-07 | ダウングレード | BofA Securities | Buy → Underperform |
2024-05-07 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2024-05-07 | ダウングレード | Jefferies | Buy → Hold |
2024-05-06 | ダウングレード | William Blair | Outperform → Mkt Perform |
2023-10-06 | 再開されました | BTIG Research | Buy |
2023-08-31 | 開始されました | H.C. Wainwright | Buy |
2022-05-24 | 開始されました | Cantor Fitzgerald | Overweight |
2020-05-26 | 開始されました | BTIG Research | Buy |
2020-05-26 | 開始されました | BofA/Merrill | Buy |
2020-05-26 | 開始されました | Jefferies | Buy |
2020-05-26 | 開始されました | William Blair | Outperform |
すべてを表示
Lyra Therapeutics Inc (LYRA) 最新ニュース
How high can Lyra Therapeutics Inc. stock price go in 2025Free Bull & Bear Market Updates - jammulinksnews.com
What makes Lyra Therapeutics Inc. stock price move sharplyHigh Return Potential - Newser
Is Lyra Therapeutics Inc. a good long term investmentUnstoppable trading performance - Autocar Professional
Lyra Therapeutics Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional
What analysts say about Lyra Therapeutics Inc. stockRobust financial gains - Autocar Professional
What drives Lyra Therapeutics Inc. stock priceExponential wealth increase - jammulinksnews.com
Lyra Therapeutics (LYRA) Proposes Sale of 846,744 Shares of Comm - GuruFocus
How Lyra Therapeutics Inc. stock performs during market volatilityFree Predictions - Newser
Why Lyra Therapeutics Inc. stock attracts strong analyst attentionConsistent High Return Strategy - beatles.ru
Lyra Therapeutics CFO Cavalier sells $6k in shares By Investing.com - Investing.com Canada
Lyra Therapeutics CEO Palasis sells $13944 in stock By Investing.com - Investing.com Nigeria
Lyra Therapeutics CEO Palasis sells $13944 in stock - Investing.com
Lyra Therapeutics (NASDAQ:LYRA) Downgraded to Sell Rating by Wall Street Zen - Defense World
Lyra Therapeutics (NASDAQ:LYRA) Stock Rating Upgraded by Wall Street Zen - Defense World
Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times
Lyra Therapeutics Secures $4.3M in Direct Offering - TipRanks
Is Lyra Therapeutics, Inc. overvalued or undervalued? - MarketsMojo
Lyra Therapeutics regains Nasdaq compliance as stock maintains $1 minimum - Investing.com
Lyra Therapeutics: Regulatory Pathway For Non-Polyp Patients, An Underappreciated Catalyst - Seeking Alpha
Lyra Therapeutics, Inc. (NASDAQ:LYRA) Stake Lessened by Two Sigma Investments LP - Defense World
HC Wainwright Expects Higher Earnings for Lyra Therapeutics - Defense World
Lyra Therapeutics (LYRA) Upgraded to Buy: Here's Why - sharewise
Lyra Therapeutics Inc (LYRA) 財務データ
収益
当期純利益
現金流量
EPS
Lyra Therapeutics Inc (LYRA) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Cavalier Jason | Chief Financial Officer |
Jul 10 '25 |
Sale |
8.91 |
684 |
6,094 |
519,316 |
大文字化:
|
ボリューム (24 時間):